CancerLivER: Biomarker Card

Biomarker Card: Comprehensive information about a biomarker


Biomarker ID 2454
Detailed information
CancerLivER ID2454
Biomarker XPO1
Biomarker Name/Symbol (given in Publication)XPO1
BiomoleculeRNAs
SubjectHuman
Degree of ValidityPotential biomarker and therapeutic target for HCC and upregulated in highly invasive HCC than less-invasive HCC and validated on independent dataset
Experimental Conditionless (L) invasive HCC v/s highly (H) invasive HCC; associated with survival of patients
Cancer typeHepatocellular carcinoma
RegulationUpregulated in highly invasive HCC than less-invasive HCC (with fold change of 1.44 )
Level of significance p < 0.01
SourceTissue
PMID19945130
Type of BiomarkerPrognostic
PathwayMitotic Metaphase and Anaphase and SMAD Signaling Network.
Cohort188 HCC patients, 59 were selected randomly for test analyses (V0 [HCCs without vascular invasion] = 29 cases, V1 [HCCs with microvascular invasion] = 14 cases, and V2 [HCCs with macrovascular invasion] = 16 cases), and another 129 cases were evaluated for validation analyses (V0 = 67 cases, V1 = 33
SensitivityNA
SpecificityNA
AccuracyNA
AUCNA
Diseaseless (L) invasive HCC v/s highly (H) invasive HCC
Year of Publication2010
Clinical trialNO
Clinical trial (NCT Number)NA

         Raghava's group    CancerCSP    CancerSPP    CancerPDF    CancerTSP    CancerLSP    HCCPred   

Scroll to Top